-
1
OPG/RANKL/RANK cytokine system in renal osteodystrophy
Published 2007-11-01Subjects: “…receptor activator of nuclear factor κ B ligand (RANKL)…”
Get full text
Article -
2
Aspirin inhibits RANKL-induced osteoclast differentiation in dendritic cells by suppressing NF-κB and NFATc1 activation
Published 2019-12-01Subjects: “…Receptor activator for nuclear factor-κB ligand (RANKL)…”
Get full text
Article -
3
Isoliensinine Suppresses Osteoclast Formation Through NF-κB Signaling Pathways and Relieves Ovariectomy-Induced Bone Loss
Published 2022-07-01Subjects: “…receptor activator of nuclear factor-κB ligand (RANKL)…”
Get full text
Article -
4
Exploring the therapeutic potential of isoorientin in the treatment of osteoporosis: a study using network pharmacology and experimental validation
Published 2024-02-01Subjects: “…Receptor activator of nuclear factor-κB ligand (RANKL)…”
Get full text
Article -
5
Polysaccharides Derived from <i>Drynaria fortunei</i> Attenuated Osteoclast Differentiation Induced by Receptor Activator of Nuclear Factor-κB Ligand by Modulating NFATc1 and c-Fos...
Published 2023-11-01Subjects: “…receptor activator of nuclear factor-κB ligand (RANKL)…”
Get full text
Article